Study of AzaSite Versus Vigamox in the Tears of Healthy Volunteers

NCT00575367 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections
Eye Infections

Interventions

DRUG: AzaSite (azithromycin ophthalmic solution)
DRUG: Vigamox (moxifloxacin hydrochloride ophthalmic solution)

Sponsor

Merck Sharp & Dohme LLC